Company: UHS
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000950170-25-049925
Chunk: 83

Company: UNIVERSAL HEALTH SERVICES INC
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 83
---
 on capital • Earnings before interest, taxes, depreciation and amortization, and the impacts of other income/expense and net income attributable to noncontrolling interests ("Adjusted EBITDA net of NCI")

As described in our “Compensation Discussion and Analysis”, the Compensation Committee bases the compensation decisions with respect to the named executive officers on an evaluation of one or more of objective business criteria, including the performance measures listed above. The importance of adjusted earnings per share, diluted, and return on capital is reflected in our use of these measures when setting performance standards applicable to the annual incentive compensation for our named executive officers pursuant to the 2022 Executive Incentive Plan. Performance-based restricted stock units awarded to each of our named executive officers will be earned based upon the achievement of a pre-established specified range of target levels based on the three-year growth in our Adjusted EBITDA net of NCI. Our compensation philosophy of aligning pay strongly with performance is grounded in best practices that are regulatory compliant, financially sound and provide long-term value to stockholders.

| 48                                                   |
| Universal Health Services, Inc. 2025 Proxy Statement |

| Pay Versus Performance Table |

Analysis of the Information Presented in the Pay Versus Performance Table

The following charts show the relationship between the Company’s cumulative five-year TSR and that of the industry line peer group reflected in our 2024 Annual Report on Form 10-K pursuant to Item 201(e) of Regulation S-K, as well as the relationships between CAP and the required financial performance measures in the Pay Versus Performance table above – Company TSR, net income and the Company-selected measure of adjusted earnings per share, diluted.

| 49                                                   |
| Universal Health Services, Inc. 2025 Proxy Statement |

DIRECTOR COMPENSATION

2024 Director Compensation:

The following table provides information concerning the compensation of our non-employee Directors for 2024.

| Name                    |     | Fees      
 Earned or 
 Paid in   
 Cash      
 ($)       |         |     | Grant Date 
 Fair Value 
 Stock      
 Awards(1.) 
 ($)        |         |     | Grant Date 
 Fair Value 
 Option     
 Awards     
 ($)        |   |     | Non-Equity     
 Incentive Plan 
 Compensation   
 ($)            |   |     | All Other        
 Compensation(2.) 
 ($)              |       |     | Total 
 ($)   |         |
|:------------------------|:----|:----------|--------:|:----|:-----------|--------:|: